Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 245

1.

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M.

Nutr Rev. 2017 Sep 1;75(9):731-767. doi: 10.1093/nutrit/nux047.

PMID:
28938795
2.

Sentinel lymph node biopsy in periocular merkel cell carcinoma: a case report.

Filitis DC, Paragh G, Samie FH, Zeitouni NC.

BMC Res Notes. 2017 Sep 20;10(1):490. doi: 10.1186/s13104-017-2746-y.

3.

Melanoma Suppressor Functions of the Carcinoma Oncogene FOXQ1.

Bagati A, Bianchi-Smiraglia A, Moparthy S, Kolesnikova K, Fink EE, Lipchick BC, Kolesnikova M, Jowdy P, Polechetti A, Mahpour A, Ross J, Wawrzyniak JA, Yun DH, Paragh G, Kozlova NI, Berman AE, Wang J, Liu S, Nemeth MJ, Nikiforov MA.

Cell Rep. 2017 Sep 19;20(12):2820-2832. doi: 10.1016/j.celrep.2017.08.057.

4.

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M.

Arch Med Sci. 2017 Aug;13(5):965-1005. doi: 10.5114/aoms.2017.69326. Epub 2017 Aug 4. No abstract available.

5.

Photodynamic therapy and pain: A systematic review.

Ang JM, Riaz IB, Kamal MU, Paragh G, Zeitouni NC.

Photodiagnosis Photodyn Ther. 2017 Sep;19:308-344. doi: 10.1016/j.pdpdt.2017.07.002. Epub 2017 Jul 15.

PMID:
28716738
6.

Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia.

Szentpéteri A, Zsíros N, Varga VE, Lőrincz H, Katkó M, Seres I, Fülöp P, Paragh G, Harangi M.

Vasa. 2017 Aug;46(5):370-376. doi: 10.1024/0301-1526/a000643. Epub 2017 Jun 12.

PMID:
28602123
7.

Adipokines as atherothrombotic risk factors in obese subjects: Associations with haemostatic markers and common carotid wall thickness.

Csongrádi É, Káplár M, Nagy B Jr, Koch CA, Juhász A, Bajnok L, Varga Z, Seres I, Karányi Z, Magyar MT, Oláh L, Facskó A, Kappelmayer J, Paragh G.

Nutr Metab Cardiovasc Dis. 2017 Jun;27(6):571-580. doi: 10.1016/j.numecd.2017.02.007. Epub 2017 Mar 8.

PMID:
28428025
8.

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators.

N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17.

9.

ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design.

Češka R, Paragh G, Reiner Ž, Banach M, Tokgözoğlu L, Susekov AV, Rašlová K, Freiberger T, Vohnout B, Rynkiewicz A, Goudev A, Dan GA, Gaiţă D, Pojskić B, Pećin I, Kayıkçıoğlu M, Mitchenko O, Ezhov MV, Latkovskis G, Petrulionienė Ž, Fras Z, Tasić N, Mirrakhimov EM, Murataliev T, Shek AB, Tuka V, Tselepis AD, Moubarak EM, Rasadi KA.

Vnitr Lek. Winter 2017;63(1):43-48.

PMID:
28225290
10.

ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology.

Češka R, Freiberger T, Susekov AV, Paragh G, Reiner Ž, Tokgözoğlu L, Rašlová K, Banach M, Vohnout B, Rynkiewicz A, Goudev A, Dan GA, Gaiţă D, Pojskić B, Pećin I, Kayıkçıoğlu M, Mitchenko O, Ezhov MV, Latkovskis G, Petrulionienė Ž, Fras Z, Tasić N, Mirrakhimov EM, Murataliev T, Shek AB, Tuka V, Tselepis AD, Moubarak EM, Al Rasadi K.

Vnitr Lek. Winter 2017;63(1):25-30.

PMID:
28225288
11.

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.

Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR; EUCLID Trial Steering Committee and Investigators.

N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13.

12.

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.

EAS Familial Hypercholesterolaemia Studies Collaboration, Vallejo-Vaz AJ, Akram A, Kondapally Seshasai SR, Cole D, Watts GF, Hovingh GK, Kastelein JJ, Mata P, Raal FJ, Santos RD, Soran H, Freiberger T, Abifadel M, Aguilar-Salinas CA, Alnouri F, Alonso R, Al-Rasadi K, Banach M, Bogsrud MP, Bourbon M, Bruckert E, Car J, Ceska R, Corral P, Descamps O, Dieplinger H, Do CT, Durst R, Ezhov MV, Fras Z, Gaita D, Gaspar IM, Genest J, Harada-Shiba M, Jiang L, Kayikcioglu M, Lam CS, Latkovskis G, Laufs U, Liberopoulos E, Lin J, Lin N, Maher V, Majano N, Marais AD, März W, Mirrakhimov E, Miserez AR, Mitchenko O, Nawawi H, Nilsson L, Nordestgaard BG, Paragh G, Petrulioniene Z, Pojskic B, Reiner Ž, Sahebkar A, Santos LE, Schunkert H, Shehab A, Slimane MN, Stoll M, Su TC, Susekov A, Tilney M, Tomlinson B, Tselepis AD, Vohnout B, Widén E, Yamashita S, Catapano AL, Ray KK.

Atheroscler Suppl. 2016 Dec;22:1-32. doi: 10.1016/j.atherosclerosissup.2016.10.001. Epub 2016 Dec 7.

13.

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia.

Varga VE, Lőrincz H, Zsíros N, Fülöp P, Seres I, Paragh G, Balla J, Harangi M.

Lipids Health Dis. 2016 Oct 18;15(1):182.

14.

The need for a new classification of cholesterol lowering therapies.

Mark L, Paragh G, Ray KK.

Curr Med Res Opin. 2017 Jan;33(1):67-69. Epub 2016 Oct 3. No abstract available.

PMID:
27599680
15.

[Up to date lipid lowering treatment].

Paragh G, Karádi I.

Orv Hetil. 2016 Jul;157(31):1219-23. doi: 10.1556/650.2016.30505. Review. Hungarian.

PMID:
27476517
16.

Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome.

Koncsos P, Fülöp P, Juhász I, Bíró K, Márk L, Simonyi G, Paragh G.

Wien Klin Wochenschr. 2016 Dec;128(23-24):858-863. Epub 2016 Jul 5.

PMID:
27380508
17.

7DHC-induced changes of Kv1.3 operation contributes to modified T cell function in Smith-Lemli-Opitz syndrome.

Balajthy A, Somodi S, Pethő Z, Péter M, Varga Z, Szabó GP, Paragh G, Vígh L, Panyi G, Hajdu P.

Pflugers Arch. 2016 Aug;468(8):1403-18. doi: 10.1007/s00424-016-1851-4. Epub 2016 Jun 17.

PMID:
27315086
18.

Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications.

Zsíros N, Koncsos P, Lőrincz H, Seres I, Katkó M, Szentpéteri A, Varga VE, Fülöp P, Paragh G, Harangi M.

Clin Biochem. 2016 Aug;49(12):862-7. doi: 10.1016/j.clinbiochem.2016.03.011. Epub 2016 Apr 26.

PMID:
27129797
19.

Paraoxonase-1 and adipokines: Potential links between obesity and atherosclerosis.

Fülöp P, Harangi M, Seres I, Paragh G.

Chem Biol Interact. 2016 Nov 25;259(Pt B):388-393. doi: 10.1016/j.cbi.2016.04.003. Epub 2016 Apr 7. Review.

PMID:
27062889
20.

High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.

Gaál K, Tarr T, Lőrincz H, Borbás V, Seres I, Harangi M, Fülöp P, Paragh G.

Lipids Health Dis. 2016 Mar 22;15:60. doi: 10.1186/s12944-016-0229-0.

Supplemental Content

Loading ...
Support Center